Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease
Overview
Authors
Affiliations
Objective: To determine the number and function of follicular helper T (Tfh) cell subsets in IgG4-related disease (IgG4-RD).
Methods: Mononuclear cells from the peripheral blood and involved tissue of patients with IgG4-RD were assessed for Tfh cells and their subsets, and levels of B cell lymphoma 6 (Bcl-6), B lymphocyte-induced maturation protein 1 (BLIMP-1), and interleukin-21 (IL-21) messenger RNA (mRNA). Immunohistochemical and immunofluorescence techniques were used to assess the involved tissue of patients to determine the location of IL-21, Bcl-6, and CD4+CXCR5+ Tfh cells. Furthermore, the ability of circulating Tfh (cTfh) cell subsets to induce B cell proliferation, apoptosis, and differentiation and to produce IgG4 was explored in cell cocultures in vitro.
Results: Frequencies of cTfh cells were significantly increased in the peripheral blood of patients with IgG4-RD, and even higher frequencies were observed in the involved tissue. Percentages of programmed cell death protein 1 in CD4+CXCR5+ICOS+ cTfh cells were positively correlated with the serum levels of IgG and IgG4, IgG4:IgG ratio, number of involved organs, and frequency of CD19+CD24-CD38 plasmablasts/plasma cells. Levels of BLIMP-1 and IL-21 mRNA in peripheral CD4+ T cells were increased in patients with IgG4-RD compared to healthy controls, and this was correlated with the levels of serum IgG4. Moreover, in the involved tissue, Bcl-6, IL-21, and Tfh cells were highly expressed. Compared to cTfh cells from healthy controls, cTfh cells from patients with IgG4-RD could facilitate B cell proliferation and inhibit B cell apoptosis more efficiently, and enhanced the differentiation of naive B cells into switched memory B cells and plasmablasts/plasma cells, with a resultant increase in the secretion of IgG4. Notably, the cTfh1 and cTfh2 cell subsets were the most effective at providing B cell help.
Conclusion: Tfh cell subsets are expanded in IgG4-RD and may play pivotal roles in the pathogenesis of the disease.
Recent Evidence of the Role of CD4 T Cell Subsets in IgG4-related Disease.
Kamekura R, Sakamoto H, Yajima R, Yamamoto K, Okuni T, Yamamoto M JMA J. 2025; 8(1):40-47.
PMID: 39926068 PMC: 11799721. DOI: 10.31662/jmaj.2024-0096.
Immune Profile Differences between IgG4-Related Diseases and Primary Sjögren's Syndrome.
Qin Y, Shang L, Wang Y, Feng M, Liang Z, Wang N J Inflamm Res. 2025; 18:911-923.
PMID: 39871956 PMC: 11770921. DOI: 10.2147/JIR.S471266.
Akiyama M, Alshehri W, Saito K, Takeuchi T, Kaneko Y Drugs Aging. 2025; 42(2):111-126.
PMID: 39755996 DOI: 10.1007/s40266-024-01172-3.
Hara A, Watanabe T, Minaga K, Yoshikawa T, Kurimoto M, Sekai I JCI Insight. 2024; 9(20).
PMID: 39264798 PMC: 11529986. DOI: 10.1172/jci.insight.167910.
Jung Y, Agrawal S, Wang B, Gupta S Dermatopathology (Basel). 2024; 11(3):218-229.
PMID: 39051325 PMC: 11270352. DOI: 10.3390/dermatopathology11030023.